|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
| Trial Status | Open |
| Dates | Date of activation: 14/01/2004 |
| Data management at EORTC | Mailbox |
| Phase | 3 |
| Randomized trial | Yes |
| Type | Adjuvant |
| Targeted Sample size | EORTC Groups: 360 - All Groups: 3000 |
| Number of steps | 1 |
| Drug | Exemestane (FCE 24304) Triptorelin Tamoxifen |
| Study Staff | Marc Debled (Study Coordinator) - Institut Bergonie, Bordeaux Jan Bogaerts (Statistician) - EORTC, Brussels Peter De Burghgraeve (Data Manager) - EORTC, Brussels Yue Song (Project Manager) - EORTC, Brussels, yue.song( at )eortc.be, +32 2 7741628 |
| Type of cancer | Breast |
| Participating Groups | International Breast Cancer Study Group(Coordinating Group) EORTC Breast Cancer Group Oncology Site Management Organization |
| Currently authorized centers | ZNA Middelheim (Antwerpen, Belgium) - Inst. 114 Cliniques Universitaires St. Luc (Brussels, Belgium) - Inst. 121 Centre Hospitalier Etterbeek Ixelles (Brussels, Belgium) - Inst. 127 U.Z. Gasthuisberg (Leuven, Belgium) - Inst. 147 C.H.U. Sart-Tilman (Liege, Belgium) - Inst. 155 Hopital De Jolimont (Haine St Paul, Belgium) - Inst. 474 H. Hartziekenhuis (Roeselare, Belgium) - Inst. 1200 Clinique Sainte Elisabeth (Namur, Belgium) - Inst. 1201 Algemeen Ziekenhuis Sint-Augustinus (Wilrijk, Belgium) - Inst. 1234 Clinique Hartmann (Neuilly-Sur-Seine, France) - Inst. 2299 Clinique De Valdegour (Nimes, France) - Inst. 2308 Polyclinique Bordeaux-Nord Aquitaine (Bordeaux, France) - Inst. 2359 Clinique Etienne Dolet (Saint Nazaire, France) - Inst. 9085 Clinique de l'Alliance (St Cyr sur Loire, France) - Inst. 9089 C.H.R.U. De Limoges (Limoges, France) - Inst. 469 Centre Henri Becquerel (Rouen, France) - Inst. 208 Centre Claudius Regaud (Toulouse, France) - Inst. 209 Centre Jean Godinot (Reims, France) - Inst. 219 Institut Gustave Roussy (Villejuif, France) - Inst. 225 Centre Leon Berard (Lyon, France) - Inst. 227 Institut Bergonie (Bordeaux, France) - Inst. 228 Centre Georges-Francois-Leclerc (Dijon, France) - Inst. 229 Centre Rene Gauducheau (Nantes - St. Herblain, France) - Inst. 235 Centre Jean Perrin (Clermont-Ferrand, France) - Inst. 241 Centre Rene Huguenin (Saint-Cloud, France) - Inst. 252 Institut Curie (Paris, France) - Inst. 259 Centre Eugene Marquis (Rennes, France) - Inst. 272 Hopital Jean Bernard (Poitiers, France) - Inst. 296 Assaf Harofeh Medical Center (Zerifin, Israel) - Inst. 3814 Rambam Medical Center (Haifa, Israel) - Inst. 910 I.P.O. Francisco Gentil - Centro De Lisboa (Lisboa, Portugal) - Inst. 801 The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, The Netherlands) - Inst. 301 Onze Lieve Vrouw Gasthuis (Amsterdam, The Netherlands) - Inst. 309 Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310 Marmara University Hospital (Istanbul, Turkey) - Inst. 971 |
| Protocol summary | Link provided by NCI PDQ |